OSR Holdings, Inc. (OSRHW) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 4Aug 11Aug 14Aug 19Aug 24Sep 3Sep 9Sep 14

Key dataSep 14, 2026

Open$0.02

From 52W high−60.19%

Volume0.00

Market cap$133115.40

P/E (TTM)—

P/S (TTM)0.1x

Div yield—

Key dataSep 14, 2026

Open

$0.02

From 52W high

−60.19%

Volume

0.00

Market cap

$133115.40

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

−2.6x

P/E (TTM)

—

RSI (14)

37.8

MomentumView details →

1D Return

−1.00%

YTD Return

−60.78%

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

—

EV/EBITDA

−2.6x

EV/Sales

11.0x

P/S (TTM)

0.1x

P/B (TTM)

0.0x

ProfitabilityView details →

Gross Margin

−98.82%

Net Margin

−836.91%

EBITDA Margin

−423.86%

ROE (TTM)

−14.52%

ROA (TTM)

−9.08%

Asset Turnover

0.01x

GrowthView details →

Revenue YoY

+351.82%

EPS YoY

−16.42%

FCF YoY

—

Revenue CAGR 3Y

−17.69%

EPS CAGR 3Y

—

EBITDA YoY

−74.71%

MomentumView details →

1D Return

−1.00%

YTD Return

−60.78%

1Y Return

−53.49%

RSI (14)

37.8

vs 50D SMA

−53.64%

vs 200D SMA

−61.41%

Capital & dividendView details →

Debt/Equity

0.01x

Current Ratio

0.18x

Quick Ratio

0.14x

Div Yield

—

Div Rate

—

Div Growth 1Y

—

EarningsView details →

EPS (Actual)

−$0.03

EPS Surprise

88.50%

Beats (12Q)

2/12

Next Q EPS Est

−$0.27

Avg Surprise (4Q)

78.73%

Rev Surprise

−59.53%

Financials snapshotView financials →

Revenue (TTM)

1.81M

Net Income (TTM)

−15.14M

Op. CF (TTM)

−7.20M

Next earningsDec 2, 2026 →

Latest newsMore news →

OSR Holdings, Inc. changed its corporate name to OSR Health, Inc., effective June 11, 2026.90d ago

OSR Holdings, Inc. agreed to purchase all of Vaximm AG's right, title and interest in the VXM01 intellectual property family and certain related assigned contracts for $30 million.111d ago

Similar companies

Humacyte, Inc.HUMAW Altamira Therapeutics Ltd.CYTO SAB Biotherapeutics, Inc.SABSW Instinct Bio Technical Company Holdings Inc. WarrantsBIOTW Jasper Therapeutics, Inc.JSPRW Vincerx Pharma, Inc.VINC Find similar companies →

Latest newsMore news →

OSR Holdings, Inc. changed its corporate name to OSR Health, Inc., effective June 11, 2026.90d ago OSR Holdings, Inc. agreed to purchase all of Vaximm AG's right, title and interest in the VXM01 intellectual property family and certain related assigned contracts for $30 million.111d ago Vaximm AG granted BCM Europe AG an exclusive, worldwide license to develop, manufacture and commercialize products based on VXM01.111d ago